TICKVALE
>⌘K
Nasdaq · CIK 0001104506 · PHARMACEUTICAL PREPARATIONS

INSMED INC

INSM chart by TradingView
P/E P/B 30.6xP/SALES 20.4xEV/EBITDA FCF YIELD -3.49%

PRICE HISTORY

LIVE · NASDAQ
INSM chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$0.6B
EBITDA
$-1.2B
FREE CASH FLOW
$-1.0B
EPS
$-6.42
GROSS MARGIN
79.73%
ROIC
-165.92%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

LATEST · Q2 FY26
Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

P / SALES (TTM)

20.4x
-38%
LATEST · Q2 FY26
20.4xQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
9.0x102.8x

P / BOOK

30.6x
+747%
LATEST · Q2 FY26
30.6xQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.6x267.0x

EV / EBITDA (TTM)

LATEST · Q2 FY26
Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EV / REVENUE (TTM)

20.4x
-28%
LATEST · Q2 FY26
20.4xQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
8.9x89.7x

FCF YIELD (TTM)

-3.49%
+4.7pp
LATEST · Q2 FY26
-3.49%Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-26.81%-2.62%

DIVIDEND YIELD (TTM)

LATEST · Q2 FY26
Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$0.4B
+3600%
LATEST · Q2 FY26
0.4BQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

$0.0B
+$0.0B
LATEST · Q2 FY26
0.0BQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$-0.0B
$0.0B
LATEST · Q2 FY26
-0.0BQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$-0.06
+$0.22
LATEST · Q2 FY26
-0.06Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

296.11%
-68.6pp
LATEST · Q2 FY26
296.11%Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-9.39%364.75%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

-22.35%
+25.0pp
LATEST · Q2 FY26
-22.35%Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-744.19%-22.35%

RETURN ON CAPITAL

-115.74%
-29.2pp
LATEST · Q2 FY26
-115.74%Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-1089.93%2186.70%

RETURN ON EQUITY (TTM)

-115.55%
-74.3pp
LATEST · Q2 FY26
-115.55%Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-2067.84%-32.80%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN84.20%
OPERATING MARGIN-0.36%
NET MARGIN-3.11%
FCF MARGIN-22.35%
186.06-118.62-423.30-727.97-1032.65GROSSOPERNETFCFQ1 FY13Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$-0.1B
$0.1B
LATEST · Q2 FY26
-0.1BQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.0B
+932%
LATEST · Q2 FY26
0.0BQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.0B
+1797%
LATEST · Q2 FY26
0.0BQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

0.22B
+584%
LATEST · Q2 FY26
0.22BQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

LATEST · Q2 FY26
Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$0.5B
+630%
LATEST · Q2 FY26
0.5BQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

$0.5B
+2681%
LATEST · Q2 FY26
0.5BQ1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

LATEST · Q2 FY26
Q1 FY13Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 105.13%INSIDERS 0.51%OTHER / RETAIL 0.00%976 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
JPMORGAN CHASE & CO11.14%24.2M$3.17B+4.1%
Darwin Global Management, Ltd.7.75%16.8M$2.20B-19.7%
Blackrock Inc.7.69%16.7M$2.19B+10.7%
FMR, LLC6.07%13.2M$1.73B+32.6%
Vanguard Portfolio Management LLC4.79%10.4M$1.36BNEW
Vanguard Capital Management LLC4.45%9.6M$1.26BNEW
Baker Bros. Advisors, LP3.42%7.4M$972.9M+12.6%
Artisan Partners Limited Partnership3.01%6.5M$855.7M+34.8%
Invesco Ltd.3.00%6.5M$853.8M-13.4%
Shaw D.E. & Co., Inc.2.60%5.6M$737.5M+29.3%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.